Communicating information in an emergency preparedness pill distribution campaign

Biosecurity and Bioterrorism

Volumn 6, Issue 1, 2008, Pages 57-65

  Blando, James D ^a,b   Robertson, Corwin ^a   Bresnitz, Eddy ^a  

^a NEW JERSEY DEPARTMENT OF HEALTH AND SENIOR SERVICES   (United States)

^b NJ Department of Health and Senior Services   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DRUG; POTASSIUM IODIDE;

ARTICLE; ATTITUDE TO HEALTH; BIOLOGICAL WARFARE; DISASTER PLANNING; EMERGENCY HEALTH SERVICE; HUMAN; INFORMATION DISSEMINATION; INFORMATION PROCESSING; INFORMATION SERVICE; INTERPERSONAL COMMUNICATION; PUBLIC HEALTH SERVICE; UNITED STATES;

BIOTERRORISM; COMMUNICATION; DATA COLLECTION; DISASTER PLANNING; EMERGENCY MEDICAL SERVICES; HEALTH KNOWLEDGE, ATTITUDES, PRACTICE; HUMANS; INFORMATION DISSEMINATION; INFORMATION SERVICES; PHARMACEUTICAL PREPARATIONS; POTASSIUM IODIDE; PUBLIC HEALTH ADMINISTRATION; UNITED STATES;

EID: 41849086292     PISSN: 15387135     EISSN: None     Source Type: Journal    
DOI: 10.1089/bsp.2007.0052     Document Type: Article

References (14)

1. Becker DV, Zanzonico P. Potassium iodide for thyroid blockade in a reactor accident: administrative policies that govern its use. Thyroid 1997:7(2) : 193-197.
2. Nauman J, Wolff J. Iodide prophylaxis in Poland after the Chernobyl reactor accident: benefits and risks. Am J Med 1993;94(5):524-532.
3. Le Guen B, Hemidy PY, Garcier Y. French approach for the distribution of iodine tablets in the vicinity of nuclear power plants. Health Phys 2002;83(2):293-300.
4. Millership S. Distribution of stable iodine in a nuclear emergency - are we prepared? J Public Health Med 1998;20(2): 191-195.
5. Astbury J, Horsley S, Gent N. Evaluation of a scheme for the pre-distribution of stable iodine (potassium iodate) to the civilian population residing within the immediate countermeasures zone of a nuclear submarine construction facility. J Public Health Med 1999;21 (4):412-414.
6. Consideration of potassium iodide in emergency plans final rule, 10 CFR 50. Nuclear Regulatory Commission. Fed Regist Jan 19, 2001;66(13):5427-5440.
7. Ceccato MG, Acurcio FA, Bonolo Pde F, Rocha GM, Guimaraes MD. HIV patients' understanding of information on antiretroviral therapy. Cad Saude Publica 2004;20(5): 1388-1397.
8. Mortensen MG, Kiyak HA, Omnell L. Patient and parent understanding of informed consent in orthodontics. Am J Orthod Dentofacial Orthop 2003;124(5):541-550.
9. Chapman K, Abraham C, Jenkins V, Fallowfield L. Lay understanding of terms used in cancer consultations. Psychooncology 2003;12(6):557-566.
10. Schillinger D, Piette J, Grumbach K, et al. Closing the loop: physician communication with diabetic patients who have low health literacy. Arch Intern Med 2003 Med 2003;163(1):83-90.
11. Winder A, Hossain Z, Reddy S. The health effects of ionizing radiation: a survey of local health officials in New England and New York. Public Health Rep 1994;109(2):219-227.
12. Blando J, Robertson C, Pearl K, Dixon C, Valcin M, Bresnitz E. Assessment of potassium iodide (KI) distribution program among communities within the emergency planning zones (EPZ) of two nuclear power plants. Health Phys 2007;92(2 Suppl 1):S18-S26.
13. Blando J, Robertson C, Pearl K, Dixon C, Valcin M, Bresnitz E. Evaluation of KI prophylaxis knowledge and nuclear emergency preparedness-New Jersey, 2005. Am J Public Health 97(Suppl 1):S100-S102.
14. Blando J, Robertson C, Bresnitz E. Final Report: Assessment of Potassium Iodide (KI) Distribution Campaign and Emergency Response Around New Jersey's Nuclear Power Facilities. Trenton, NJ: New Jersey Department of Health and Senior Services; 2007. http://nj.gov/health/eoh/suiTweb/documents/ ki_finalrpt.pdf. Accessed January 14, 2008.